Novartis

Historical price data

Novartis is an innovative medicines company with over 250 years of heritage and 30 years as Novartis, dedicated to reimagining medicine to improve and extend people's lives. The company operates across four core therapeutic areas with high unmet medical needs and leverages multiple technology platforms including chemistry, biotherapeutics, xRNA, radioligand therapy, and gene and cell therapy. With a global footprint spanning 118 countries and a mission to become the most valued and trusted medicines company in the world, Novartis continues to deliver high-value medicines through technology leadership in R&D and novel access approaches.

Novartis operates six technology platforms including chemistry, biotherapeutics, xRNA, radioligand therapy, gene therapy, and cell therapy to develop cutting-edge innovative medicines across multiple therapeutic modalities.

1000 drugs in pipeline, 797 in Phase 3

Novartis competes with pharmaceutical giants like Roche, Pfizer, Johnson & Johnson, and Merck but differentiates itself through its comprehensive six-platform technology approach spanning traditional molecules to cutting-edge gene and cell therapies. The company's focus on high unmet medical needs and novel access approaches provides competitive advantages in underserved markets.